| CL3111 |
|
109511-58-2 |
1,4-二氨基-2,3-二氰基-1,4-双(邻氨基苯巯基)丁二烯
U0126 (Synonyms: MEK1/2抑制剂 )
-
98+%
|
需询价 |
C18H16N6S2 |
|
|
|
| CL3091 |
|
905281-76-7 |
|
需询价 |
C19H18N4O2 |
|
|
|
| CL2230 |
|
334949-59-6 |
|
需询价 |
C25H24N4O2 |
|
|
|
| CL2945 |
|
305350-87-2 |
3-氨基-3-((4-氨基苯基)硫基)-2-(2-(三氟甲基)苯基)丙烯腈
SL 327
-
98+%
|
需询价 |
C16H12F3N3S |
|
|
|
| HL1760 |
|
526-07-8 |
芝麻林素 | 芝麻灵
Sesamolin
-
98+%
|
需询价 |
C20H18O7 |
|
|
|
| HL1732 |
|
240423-23-8 |
沙尔威辛 | (±)-沙尔威辛
Salvicine
-
98+%
|
需询价 |
C20H26O4 |
|
|
|
| CL2932 |
|
271576-80-8 |
3-[N-(2-羟基乙酰基)-4-哌啶基]-4-(4-嘧啶基)-5-(4-氯苯基)吡唑
SD-06 | SD-0006
-
98+%
|
需询价 |
C20H20ClN5O2 |
|
|
|
| CL2914 |
|
193551-21-2 |
反式-1-(4-羟基环己基)-4-(4-氟苯基)-5-(2-甲氧基嘧啶-4-基)咪唑
SB-239063
-
98+%
|
需询价 |
C20H21FN4O2 |
|
|
|
| CL2908 |
|
152121-53-4 |
PD 169316
PD 169316
3-5days
98+%
|
￥466.00 |
C20H13FN4O2 |
|
|
|
| CL2898 |
|
303162-79-0 |
|
需询价 |
C24H21N3OS |
|
|
|
| CL2855 |
|
606143-89-9 |
比美替尼 | 贝美替尼
Binimetinib (Synonyms:MEK162; ARRY-162; ARRY-438162)
-
98+%
|
需询价 |
C17H15BrF2N4O3 |
|
|
|
| CL2830 |
|
2729996-45-4 |
|
需询价 |
C26H22FN5O2 |
|
|
|
| HL1531 |
|
511-05-7 |
柳杉酚 | 10-脱氧代黄桧醇
Sugiol | (+)-Sugiol | 10-Deoxoxanthoperol
-
98+%
|
需询价 |
C20H28O2 |
|
|
|
| CL2747 |
|
1448428-04-3 |
司隆色替 | 瑟隆舍替
Selonsertib | GS-4997 | Selonsertib (free base)
-
98+%
|
需询价 |
C24H24FN7O |
|
|
|
| CL2728 |
|
152121-30-7 |
SB 202190
SB 202190 (Synonyms: SB202190; FHPI)
-
98+%
|
需询价 |
C20H14 FN3O |
|
|
|
| CL2485 |
|
212631-79-3 |
2-[(2-氯-4-碘苯基)氨基]-N-(环丙基甲氧基)-3,4-二氟-苯甲酰胺
PD184352(Synonyms: CI-1040)
3-5days
98+%
|
￥400.00 |
C17H14ClF2 IN2O2 |
|
|
|
| CL2469 |
|
309913-42-6 |
SX 011/SX-011
SX 011/SX-011
3-5days
98+%
|
￥1780.00 |
C26H27ClFN3O3 |
|
|
|
| CL2095 |
|
918504-65-1 |
维罗非尼
Vemurafenib (PLX 4032)
3-5days
98+%
|
￥560.00 |
C23H18ClF2N3O3S |
|
|
|
| CL1115 |
|
745833-23-2 |
2-(2,4-二氟苯基)-6-(1-(2,6-二氟苯基)脲基)烟酰胺
VX-702
-
98+%
|
需询价 |
C19H12F4N4O2 |
|
|
|
| CL1281 |
|
869886-67-9 |
Ulixertinib (BVD-523, VRT752271)
Ulixertinib (Synonyms: BVD-523; VRT752271)
-
98+%
|
需询价 |
C21H22Cl2N4O2 |
|
|
|
